Japan on Thursday approved Gilead Sciences Inc’s remdesivir as a treatment for COVID-19 TOKYO (Reuters) – Japan on Thursday approved Gilead Sciences Inc’s remdesivir as a treatment for COVID-19, making it the country’s first officially authorized drug to tackle the coronavirus disease. Japan reached the decision just three days after the U.S. drugmaker filed for […]